4//SEC Filing
Camardo Daniel A. 4
Accession 0001209191-21-013376
CIK 0001492426other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:18 PM ET
Size
8.7 KB
Accession
0001209191-21-013376
Insider Transaction Report
Form 4
Camardo Daniel A.
EVP and President, U.S.
Transactions
- Exercise/Conversion
Ordinary Shares
2021-02-21+1,300→ 46,376 total - Exercise/Conversion
Restricted Stock Units
2021-02-21−1,300→ 0 totalFrom: 2021-02-21Exp: 2021-02-21→ Ordinary Shares (1,300 underlying) - Tax Payment
Ordinary Shares
2021-02-21$88.87/sh−576$51,189→ 45,800 total
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001820365
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 6:18 PM ET
- Size
- 8.7 KB